Clinical Efficacy of TroVax in the Treatment of Progressive Castration-resistant Prostate Cancer

Clinical Efficacy of TroVax in the Treatment of Progressive Castration-resistant Prostate Cancer

Show other versions (1)

Bibliographic Details
Main Authors:	Robert J. Amato, Mika Stepankiw
Format:	Article
Language:	English
Published:	SAGE Publishing 2012-01-01
Series:	Clinical Medicine Insights: Oncology
Online Access:	http://la-press.com/clinical-efficacy-of-trovax-in-the-treatment-of-progressive-castration-a2973

Similar Items

Clinical Efficacy of TroVax in the Treatment of Progressive Castration-resistant Prostate Cancer
by: Robert J. Amato, et al.
Published: (2012-01-01)

An update on TroVax&reg; for the treatment of progressive castration-resistant prostate cancer
by: Abern M, et al.
Published: (2011-05-01)

A phase II study immunologically evaluating 5T4-MVA (TroVax) in patients undergoing surgical resection of colorectal liver metastases
by: Dangoor, Adam
Published: (2011)

A single centre phase II trial to assess the immunological activity of TroVax® plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma – the SKOPOS trial
by: Jason F Lester, et al.
Published: (2018-12-01)

Somatostatin analogs in the treatment of castrate-resistant prostate cancer: efficacy and tolerability
by: G. P. Kolesnikov, et al.
Published: (2016-09-01)

Clinical Development of Cabazitaxel for the Treatment of Castration-Resistant Prostate Cancer
by: Che-Kai Tsao, et al.
Published: (2011-01-01)

Treatment outcomes of progressive site-directed therapy for oligo-progressive castration-resistant prostate cancer
by: S. Yoshida, et al.
Published: (2020-07-01)

Association of Body Composition With Survival and Treatment Efficacy in Castration-Resistant Prostate Cancer
by: Sahyun Pak, et al.
Published: (2020-04-01)

Clinical use of abiraterone in the treatment of metastatic castration-resistant prostate cancer
by: Zobniw CM, et al.
Published: (2014-08-01)

TAXANES IN THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
by: T. N. Skvortsova, et al.
Published: (2017-01-01)

Optimal treatment for castration-resistant prostate cancer
by: Kouji Izumi, et al.
Published: (2014-06-01)

Recent Progress in Pharmaceutical Therapies for Castration-Resistant Prostate Cancer
by: Qingzhong Hu, et al.
Published: (2013-07-01)

Predictive factors for progression to metastatic castration-resistant prostate cancer
by: TAN Xintao, et al.
Published: (2021-03-01)

Predictors for progression of metastatic prostate cancer to castration-resistant prostate cancer in Indians
by: Sanjoy Kumar Sureka, et al.
Published: (2016-01-01)

Apalutamide in the treatment of castrate-resistant prostate cancer: evidence from clinical trials
by: Vadim S. Koshkin, et al.
Published: (2018-12-01)

Phase II Study of Pomalidomide in Patients with Castration-Resistant Prostate Cancer
by: Robert Knight, et al.
Published: (2011-09-01)

The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate Cancer
by: Jennifer H. Gunter, et al.
Published: (2012-01-01)

Upregulation of erythropoietin and erythropoietin receptor in castration-resistant progression of prostate cancer
by: Chen Ye, et al.
Published: (2020-01-01)

20(S)-protopanaxadiol inhibition of progression and growth of castration-resistant prostate cancer.
by: Bo Cao, et al.
Published: (2014-01-01)

Recent advances on the progressive mechanism and therapy in castration-resistant prostate cancer
by: Wang K, et al.
Published: (2018-05-01)

Castration-Resistant Prostate Cancer: Mechanisms, Targets, and Treatment
by: Teresa Maria Santos Amaral, et al.
Published: (2012-01-01)

Radium-223 for the treatment of castration-resistant prostate cancer
by: El-Amm J, et al.
Published: (2015-05-01)

The resurgence of estrogens in the treatment of castration-resistant prostate cancer
by: H Krishna Moorthy, et al.
Published: (2019-01-01)

Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
by: Rodriguez-Vida A, et al.
Published: (2015-06-01)

Treatment sequencing in metastatic castrate-resistant prostate cancer
by: Oliver Sartor, et al.
Published: (2014-06-01)

State-Of-The-Art Treatment in Castration-Resistant Prostate Cancer
by: Elena Castro, et al.
Published: (2014-11-01)

New developments in the treatment of castration resistant prostate cancer
by: Roxanne Wadia, et al.
Published: (2014-08-01)

Abiraterone in the treatment of metastatic castration-resistant prostate cancer
by: Mostaghel EA
Published: (2014-01-01)

Evidence for the efficacy of enzalutamide in postchemotherapy metastatic castrate-resistant prostate cancer
by: Fred Saad
Published: (2013-08-01)

Safety and efficacy of cabazitaxel in Japanese patients with castration-resistant prostate cancer
by: Teppei Yamamoto, et al.
Published: (2020-03-01)

Radium 223 in metastatic castration resistant prostate prostate. Effectiveness in clinical practice
by: M.C. Salas Buzón, et al.
Published: (2020-11-01)

Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer
by: Jingsong Zhang, et al.
Published: (2017-11-01)

The Vax operator manual
by: Sharma, Sureshchandra B.
Published: (1983)

Response and Resistance in Castration-Resistant Prostate Cancer
Published: (2020)

Darolutamide For Castration-Resistant Prostate Cancer
by: Bastos DA, et al.
Published: (2019-10-01)

Experience with octreotide depot in the treatment of castration-resistant prostate cancer
by: G. P. Kolesnikov
Published: (2015-06-01)

The role of cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
by: Che-Kai Tsao, et al.
Published: (2014-06-01)

The changing landscape in the treatment of metastatic castration-resistant prostate cancer
by: Joelle El-Amm, et al.
Published: (2013-01-01)

Update on options for treatment of metastatic castration-resistant prostate cancer
by: Prakash Vishnu, et al.
Published: (2010-03-01)

Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer
by: Mark N Stein, et al.
Published: (2014-06-01)